ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

History: Breast Cancer Screening A 30-Year War Against “Confusion”

November 20, 2009

Community Center Group To Consider “Clinical Standards, Medical Audit”

September 13, 1974

In Brief: Hendrix To Head Children’s Memorial Institute

June 20, 2003

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

Varmus: Plan Would Give Trials A Strong Scientific Base

December 17, 2010

Prostate Ultrasound Markers Concepts Approved by BSC

October 3, 1986